Rabsch W, Tschape H, Baumler AJ. Non-typhoidal salmonellosis: emerging problems. Microbes and Infection
2001; 3: 237–247.
Olsen SJ, et al.
The changing epidemiology of salmonella: trends in serovars isolated from humans in the United States, 1987–1997. Journal of Infectious Disease
2001; 183: 753–761.
Majowicz SE, et al.
The global burden of nontyphoidal salmonella gastroenteritis. Clinical Infectious Disease
2010; 50: 882–889.
Huehn S, et al.
Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in Europe. Foodborne Pathogen and Diseases
2010; 7: 523–535.
Fantasia M, et al.
Conventional and molecular approaches to isolates of Salmonella Hadar from sporadic and epidemic cases. Journal of Applied Microbiology
1997; 82: 494–498.
Di Giannatale E, et al.
Investigation of an outbreak of Salmonella enterica subsp. enterica serovar Hadar food illness in the Abruzzi region of Italy. Veterinary Italian
2008; 44: 405–427.
Lenglet A. Over 2000 cases so far in Salmonella Hadar outbreak in Spain associated with consumption of pre-cooked chicken, July–August, 2005. Eurosurveillance
2005; 11: 10(8).
Hohmann EL. Nontyphoidal salmonellosis. Clinial Infectious Disease
2001; 32: 263–269.
Anon. World Health Organisation: tackling antibiotic resistance from a food safety perspective in Europe. Copenhagen, 2011.
Parry CM. Antimicrobial drug resistance in Salmonella enterica
. Current Opinion in Infectious Diseases
2003; 16: 467–472.
Bagger-Skjøt L, et al.
Less frequent Salmonella serovars as a reservoir of antimicrobial resistance. Journal of Antimicrobial Chemotherapy
2007; 59: 814–815.
Grimont PAD, Weill FX. Antigenic Formulae of the Salmonella Serovars, 9th edn. WHO Collaborating Center for Reference and Research on Salmonella, Institut Pasteur: Paris, 2007.
CLSI. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100-S18 2008, Wayne, PA.
Hendriksen RS, et al.
Global monitoring of salmonella serovar distribution from the World Health Organization global foodborne infections network country data bank: Results of quality assured laboratories from 2001 to 2007. Foodborne Pathogens and Diseases
2011; 8: 887–900.
van den Bogaard AE, Stobberingh EE. Epidemiology of resistance to antibiotics. Links between animals and humans. International Journal of Antimicrobial Agents
2000; 14: 327–335.
Threlfall EJ, et al.
The emergence and spread of antibiotic resistance in food-borne bacteria. International Journal of Food Microbiology
2000; 62: 1–5.
O'Brien TF. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clinical Infectious Diseases
1997; 24: 2–8.
Threlfall EJ, et al.
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Eurosurveillance
2003; 8: 41–45.
Hakanen A, et al.
Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. Journal of Clinical Microbiology
1999; 37: 3572–3577.
Møller Aarestrup F, Wiuff C. Is it time to change fluoroquinolone breakpoints for Salmonella spp?
Antimicrobial Agents Chemotherapy
2003; 47: 827–829.
Crump JA, et al.
Reevaluating fluoroquinolone breakpoints for Salmonella enterica serovar Typhi and for non-typhi salmonellae. Clinical Infectious Diseases
2003; 37: 75–81.
Coque TM, Baquero F, Canton R. (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance
2008; 20: 13(47).
Hasman H, et al.
Beta-lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. Journal of Antimicrobial Chemotherapy
2005; 56: 115–121.
Yates C, Amyes S. Extended-spectrum beta-lactamases in non-typhoidal Salmonella spp. isolated in the UK are now a reality: why the late arrival?
Journal of Antimicrobial Chemotherapy
2005; 56: 262–264.